wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38392676-881C45CE-4EF2-40DD-95E0-63FC5DDAEF7B
Q38392676-881C45CE-4EF2-40DD-95E0-63FC5DDAEF7B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38392676-881C45CE-4EF2-40DD-95E0-63FC5DDAEF7B
A review of the European LeukemiaNet recommendations for the management of CML.
P2860
Q38392676-881C45CE-4EF2-40DD-95E0-63FC5DDAEF7B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38392676-881C45CE-4EF2-40DD-95E0-63FC5DDAEF7B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
09206631aad4e09fd8516f98f946fbd2ffa67eed
P2860
Nilotinib in imatinib-resistant or imatinib-intolerant patients with chronic myeloid leukemia in chronic phase: 48-month follow-up results of a phase II study.